BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21353653)

  • 21. Definition of response to antiviral therapy in chronic hepatitis C.
    Craxï A; Cammà C; Giunta M
    J Hepatol; 1999; 31 Suppl 1():160-7. PubMed ID: 10622580
    [No Abstract]   [Full Text] [Related]  

  • 22. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic hepatitis C and alcohol consumption].
    Mathurin P; Canva V; Dharancy S; Paris JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
    Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C: a critical analysis of therapeutic response predictors.
    Focaccia R; Siciliano RF; Santos ED; Boccardo E; Conceição OJ; Barbosa UO; Galante VC
    Braz J Infect Dis; 2002 Apr; 6(2):74-81. PubMed ID: 11980607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):122-8. PubMed ID: 16706823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
    J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic hepatitis C infection: one step at a time.
    Davis GL; Lindsay KL
    Lancet Infect Dis; 2005 Aug; 5(8):524-6. PubMed ID: 16048721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of hepatitis C viral infection after treatment with infliximab.
    Huang M; Huang L
    J Clin Gastroenterol; 2014 Feb; 48(2):189-90. PubMed ID: 24247815
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus treatment revolution: need for close monitoring.
    Ippolito G; Antonelli G; Capobianchi MR; Lanini S
    Clin Microbiol Infect; 2014 Nov; 20(11):O790-1. PubMed ID: 24889740
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferon-based hepatitis C antiviral treatment outcomes may be predicted by alanine aminotransferase levels.
    Kelly E; Blach S; Razavi H; Cooper C
    Can J Gastroenterol Hepatol; 2015; 29(8):407-8. PubMed ID: 26301333
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving the treatment of hepatitis C infection in the UK.
    Cooke GS; Main J
    Expert Opin Pharmacother; 2007 Feb; 8(2):183-91. PubMed ID: 17257088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C treatment.
    Damen M; Bresters D
    Curr Stud Hematol Blood Transfus; 1998; (62):181-207. PubMed ID: 9507811
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic hepatitis C with normal aminotransferase levels.
    Ahmed A; Keeffe EB
    Gastroenterology; 2004 May; 126(5):1409-15. PubMed ID: 15131801
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of children with chronic hepatitis C with IFN].
    Fujisawa T; Inui A; Komatsu H; Onoue M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):841-6. PubMed ID: 7563886
    [No Abstract]   [Full Text] [Related]  

  • 39. Active disease in chronic hepatitis C patients with normal alanine aminotransferase.
    Arif A
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):149. PubMed ID: 24640016
    [No Abstract]   [Full Text] [Related]  

  • 40. Active disease in chronic hepatitis C patients with normal alanine aminotransferase.
    Dogan UB; Akin MS
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):148. PubMed ID: 24491016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.